Reinventing Medical Gowns Sourcing Strategies through Reusability

By Steve Tracey📧Kusumal Ruamsook📧, Norman Frankel, and James J. Mangini

CSCR White paper, August 2024

Healthcare providers require a broad array of personal protective equipment (PPE) supplies to perform diagnosis and treatment. After gloves, medical gowns are the second most commonly used PPE items in healthcare settings. Over the last several years, preferences among healthcare providers worldwide have gradually shifted from reusable medical gowns to disposable ones designed to be discarded after a single use. The single use nature means that this critical supply needs to be constantly replenished. The COVID-19 pandemic has brought PPE supply chain vulnerabilities into spotlight and served as a resounding reminder that new ways of sourcing are required. Reusability can provide an impactful source of leverage in sourcing strategies aimed to enable resilience in times of crisis, as well as provide cost efficient and environmentally sustainable advantages. Nevertheless, transitioning from disposable to reusable medical gowns is by no means a simple matter of switching products purchased. After each use, reusable gowns require proper laundering to clean and remove microbicide from the potentially contaminated items before putting them back in an inventory for reuse. Not all healthcare providers have these reprocessing operations established. In this paper, we present a decision framework that takes an end-to-end supply management perspective to provide a structural thinking lens for healthcare providers embarking on the road to reinvent medical gowns sourcing strategies through reusability.

View full paper here.


Suggested citation

Tracey, Steve, Kusumal Ruamsook, Norman Frankel, and James J. Mangini. 2024. “Reinventing Medical Gowns Sourcing Strategies through Reusability.” White paper, Center for Supply Chain Research® (CSCR®), The Pennsylvania State University.


Related CSCR White Papers:

Read “Reusable Medical Device Supply Chains in a Pandemic Setting: A Case of N95 Respirators” here.

Read “Healthcare Supply Distribution and Inventory Systems” here.

Medical Device Manufacturing: Gowning Procedure Harmonization strategy

By Rohan Daftari, supervised by Robert A. Novack📧 (Thesis Supervisor) and Saurabh Bansal📧 (Honors Advisor) (2024)

Efficient and safe gowning procedures are an essential components of productive medical device manufacturing practices within a supply chain, but without standardized process for gowning existing and best practices being unique to respective firms, businesses will expose themselves to an abundance of risks if they do not focus on this topic. Specifically, a weak gowning procedure leaves firms susceptible to quality issues during production, safety concerns for employees, high unit costs of equipment, and many more serious consequences. Another issue arises through the fact that there is no common best practice for gowning in the medical device manufacturing industry, so one company’s success with gowning procedures cannot be directly transferred to another due to unique needs for each business. This thesis will analyze how a leading player in the medical device manufacturing industry, Company A, manages their gowning procedures across their global sites as well as recommend how they can improve this specific area within their supply chain to benefit the firm as a whole. Six leaders from Company A were interviewed with a standard set of questions which were made to gain insight into Company A’s current issues with gowning and areas for potential improvement. These interview results, along with data collected of gowning procedures at every global site were combined to provide employee driven recommendations. The results were compared with the limited academic research in this space and deliverables were made for company A based on these results, explaining ways they can improve their supply chain through change. The final recommendations for Company A focus on improved communication and the formation of a harmonized gowning procedure. The key takeaway from this project and thesis is finding ways to improve gowning procedures specifically for Company A, which will lead to many benefits for their overall supply chain.

Access the paper at Electronic Theses for Schreyer Honors College (ETDA) website here.

Healthcare Supply Distribution and Inventory Systems

By Steve Tracey📧 and Kusumal Ruamsook📧

CSCR White paper, October 2023

Supply distribution operations are a significant aspect of healthcare services both from the patient care quality and financial perspectives. Unlike commercial products, stockouts of critical medical supplies could result in a life-threatening situation for patients and compromised safety for medical staffs. Traditionally given a low priority, effective supply distribution and inventory management is increasingly moving into the center stage of healthcare systems due to potential improvements in terms of cost savings, patients’ satisfaction, and effectiveness of healthcare employee work flow. Shortages of critical personal protective equipment (PPE) amid the COVID-19 pandemic, the spate of mergers and acquisitions across the healthcare industry, and the high inflation rate further stimulate this shift in mindset. This paper aims to develop conceptual strategic frameworks of healthcare supply distribution network that depict variations of multi-echelon inventory and distribution network structure, echelon inventory positioning, and distribution flow models. The frameworks provide an essential basis for a healthcare system in its evaluation for decisions on system design, and strategic distribution and inventory planning for both normal operations and crisis preparedness circumstances.

View full paper here.


Suggested citation

Tracey, Steve, and Kusumal Ruamsook. 2023. “Healthcare Supply Distribution and Inventory Systems.” White paper, Center for Supply Chain Research® (CSCR®), The Pennsylvania State University.


Related CSCR White Papers:

Read “Reusable Medical Device Supply Chains in a Pandemic Setting: A Case of N95 Respirators” here.

Reusable Medical Device Supply Chains in a Pandemic Setting: A Case of N95 Respirators

By Steve Tracey📧Kusumal Ruamsook📧, Norman Frankel, and Kevin Harter

CSCR White paper, August 2023

In the event of a pandemic, there is the potential for an overwhelming influx of patients along with an increase in expanded uses for protection beyond the infected patient, resulting in a sharply increased demand for medical care resources. In this “surge use” circumstance, demand for certain medical devices could rise beyond healthcare providers’ ability to expand their supplies to match increases in demand, leading to critical supply shortages. Transmitted by respiratory droplets or airborne particles, the COVID-19 decease particularly heightens the importance of respiratory protection devices. Reuse of PPE is an effective measure to reduce pressure on supply capacity during surge use events. This measure, however, is in contrast to the current propensity towards uses of disposable devices for respiratory protection. In particular, surgical N95s are intended as a single-use device. In this paper, process flow of medical device reprocessing for reuse, respiratory supply chains, and key players are discussed.

View full paper here.


Suggested citation

Tracey, Steve, Kusumal Ruamsook, Norman Frankel, and Keven Harter. 2023. “Reusable Medical Device Supply Chains in a Pandemic Setting: A Case of N95 Respirators.” White paper, Center for Supply Chain Research® (CSCR®), The Pennsylvania State University.


Related CSCR White Paper:

Read “Healthcare Supply Distribution and Inventory Systems” here.

Focusing on Process: Leveraging Inventory Governance Practices to Improve Supply Chain Functionality

By Kyra Cunningham, supervised by Robert A. Novack📧 (Thesis Supervisor) and John C. Spychalski📧 (Honors Advisor) (2023)

Inventory governance is an area of supply chain where companies follow “best practices”, but without a definition of what these general guidelines are, some businesses open themselves up to unnecessary risk when they do not focus on this topic. Specifically, a weak structure in this area can lead to miscommunications, knowledge gaps, and lost sales, among other detrimental side effects. Another issue arises with “perfect” guidelines looking different for every company, so one company’s successes with inventory governance cannot be directly transferred to another. This thesis examines how a top healthcare and pharmaceutical supplier, Company A, manages their inventory processes as well as recommends how they can improve this area to benefit their supply chain overall. Fifteen employees from Company A were interviewed with a standard set of questions crafted to gain insight into the company’s current inventory governance procedures. The tribal data collected was analyzed to provide employee-driven process recommendations. The commonalities found were compared to limited academic research in this space; deliverables were compiled for Company A based on these results, detailing ways they can advance their business with a few changes. Final suggestions on how Company A can improve their inventory governance center around strengthened communication, increased visibility, and education. The main takeaway from this case study and thesis is finding ways to improve inventory governance specifically for Company A, which will improve their overall supply chain operations.

Access the paper at Electronic Theses for Schreyer Honors College (ETDA) website here.

Applying Lessons Learned From The COVID-19 Vaccine Distribution To Future Public Health Emergencies

By Peiqi Huang, supervised by Robert A. Novack📧 (Thesis Supervisor) and John C. Spychalski📧 (Honors Advisor) (2023)

Since the discovery of the Covid-19 virus, the development and distribution of the COVID-19 vaccine has been a global priority. After interviewing professionals in the industry, a clear picture of the COVID-19 vaccines has developed. Measures that can help speed people’s access to a COVID-19 vaccine are presented by comparing supply chains and distribution strategies for influenza (flu) vaccines and COVID-19 vaccines thereby helping the future vaccine supply chain face to adapt to new emergencies. Flu vaccines are produced by private manufacturers. Their production mostly relies on egg-based methods, with a five-to-eight-month production time, and manufacturers often start producing vaccines in January through “at-risk early production.” During transportation, flu vaccines are carefully transported in insulated containers with cold packs and heavy wrapping paper to maintain refrigerated temperatures. The COVID-19 vaccine is more sensitive to temperature changes and requires more careful handling. The COVID-19 vaccine faced supply chain constraints initially, but the pro rata formula was used to distribute limited vaccines equally based on population. In the early pandemic, states decided opened mass vaccination centers, and vaccines were shipped through UPS and FedEx. Once supply reached full capacity, vaccines were expected to be delivered from manufacturers every fifteen days. Over time, as demand is less than supply and each state has different problems. For example, there is not enough space to store the COVID-19 vaccine, and the funds are not enough to re-distribute. Distributors have to make changes to the distribution according to the situation. Overall, manufacturing and distribution challenges were faced due to the unprecedented speed and scale of vaccine production, but strategies were developed to ensure equitable distribution and on-time delivery. This can be implicated for future supply chains and help improve vaccine distribution.

Access the paper at Electronic Theses for Schreyer Honors College (ETDA) website here.

An Analysis of the United States’ Response to Securing Personal Protective Equipment Amidst COVID-19

By Jacqueline Strobel, supervised by Robert A. Novack📧 (Thesis Supervisor) and John C. Spychalski📧 (Honors Advisor) (2021)

The COVID-19 pandemic has exposed many underlying issues with the United States’ emergency response plans, as well as the supply chain system for personal protective equipment. These downfalls resulted in detrimental human and economic loss across the entire nation. No state has been spared, and the United States’ decision to act as fifty separate states, rather than one unified nation, has only aggravated the problem. At the end of this thesis, an analysis will be performed on New Zealand, a country that responded successfully to the pandemic through a universal and united strategy. This thesis will begin with an overall look into the federal and state governments’ roles in responding to national emergencies, as well as an overview on healthcare supply chain management in the United States. The thesis will then delve into the supply chain operations behind personal protective equipment, both before and during the pandemic. Next, the thesis will take a quick look at New Zealand’s overall response to COVID-19, in order to consider key discrepancies between the response in the United States. Lastly, the thesis will conclude with recommendations on how to better improve the United States’ response and outlook on the supply chain behind personal protective equipment. After careful analysis of the current state of emergency preparedness and supply chain management surrounding personal protective equipment, it is clear that the United States must make the necessary improvements to ensure the protection of the economy and health of the citizens. This analysis highlights the need for a more universal approach to emergency preparation and response, establishing a plan for an increase in domestic manufacturing of personal protective equipment, and shifting away from the just-in-time healthcare delivery system.

Access the paper at Electronic Theses for Schreyer Honors College (ETDA) website here.

Best Practices for Contingency Planning after COVID-19: An Application in the Personal Protective Equipment (PPE) Industry

By Jeffrey Ackerman, supervised by Robert A. Novack📧 (Thesis Supervisor) and John C. Spychalski📧 (Honors Advisor) (2021)

In March of 2020, the world was forever changed when the World Health Organization (WHO) declared a global pandemic due to the emergence of a disease called COVID-19. During a time of global pandemic, society attempted to slow the spread of disease before vaccinations were developed through techniques such as social distancing and the use of Personal Protective Equipment (PPE). As a result, the demand for PPE surged to historical records, and supply was not able to meet demand. This resulted in worldwide shortages for all different types of PPE, and even healthcare providers struggled to obtain the necessary PPE to protect themselves while treating COVID-19 patients. Therefore, the intent of this research is to provide a list of best practices and recommendations for contingency planning after COVID-19, specifically for the PPE industry. Current literature was reviewed and analyzed, and best practices were garnered from the literature. Three industry executives were also interviewed about their thoughts and experiences with PPE during the COVID-19 pandemic. Their opinions and recommendations were compared and contrasted with the best practices from literature, and ultimately a list of holistic best practices was developed and recommended for contingency planning. Best practices for contingency planning include enhancing the Strategic National Stockpile infrastructure, bringing more PPE manufacturing onshore in the U.S., improving end-to-end PPE inventory monitoring, filtering out misinformation on social media platforms, establishing clear guidelines on the reuse of PPE, and developing innovative ways for consumers to dispose of masks in order to mitigate environmental damage.

Access the paper at Electronic Theses for Schreyer Honors College (ETDA) website here.

Analyzing Success Case Studies in Pivoting Manufacturing Strategies to Benefit Frontline Healthcare Responders in the COVID-19 Pandemic

By Elizabeth Weiland, supervised by Robert A. Novack📧 (Thesis Supervisor) and John C. Spychalski📧 (Honors Advisor) (2020)

The COVID-19 pandemic highlighted major challenges throughout global supply chains. As the virus spread throughout the world and governments implemented various restrictions, some companies were forced to close their operations if they produced “non-essential” goods, some companies had to innovate their current facilities to adhere to the new restrictions, and many companies faced supply shortages and demand shocks. The COVID-19 pandemic is unique compared to other disruption events due it being simultaneously a regional and global event with an unclear timeline or duration as to how long the pandemic will impact the world. In addition to these disruptions, many companies and supply chains were ill-prepared in terms of having positive redundancy and risk management strategies built into their supply chains. Because of this, this thesis serves a critical role as a resource for companies that are looking to implement successful strategies into their supply chains to overcome challenges posed by a major disruption event by analyzing case studies and compiling best practices from companies that successfully accomplished this during the COVID-19 pandemic. This thesis analyzes three case studies: 3M, which successfully increased manufacturing capacity of N95 respirators; Merrow Manufacturing Company, which innovated their supply chain to produce nine types of PPE with the goal of creating a long-term sustainable supply chain for PPE in the U.S.; and Cartamundi, which temporarily pivoted their supply chains to produce plastic face shields until they can return to manufacturing their traditional product lines. From this analysis, the research found numerous commonalities of key factors that lead these companies to success. The first factor is companies were quick to successfully act when their company values were implemented and supported by the workforce and the shift a company was looking to make is aligned with those values. The second is the use of strategic relationships and established lines of communication between critical internal and external stakeholders, including suppliers, major customers, innovation and design teams, and manufacturing facilities. Thirdly, utilizing a balance of regional or domestic supply chain model, or simply having suppliers and manufacturing facilities close to the point of demand, allowed for these companies to mitigate some challenges posed by this global pandemic. Lastly, companies were able to successfully pivot their manufacturing facilities and supply chains to support the greater good and to keep their businesses open by having flexibility, adaptability, and resiliency to innovate their current processes. Learning from these key success factors and implementing these strategies can aid in building more resilient supply chains and mitigate the impacts of future major disruption events.

Access the paper at Electronic Theses for Schreyer Honors College (ETDA) website here.

Flexible Products for Dynamic Preferences

By A. Alptekinoglu📧 and K. Ramachandran

In Production and Operations Management, 2019, 28 (6): 1558–1576. https://doi.org/10.1111/poms.12990

Consumers often have needs that change in a dynamic fashion over time due to physiological, mental, or environmental variations. We develop a model to address a product strategy question on how to satisfy dynamic consumer preferences: Should a firm offer multiple standard products, each designed for a specific purpose (e.g., several specialized golf clubs), or a flexible product that can be reconfigured by consumers as their preferences change (e.g., one adjustable golf club)? Often the latter approach is fuelled by new technology, like the dial‐a‐dose system that Novo Nordisk invented and perfected over the years for its insulin pens. We find that products that deliver a high utility to consumers are ideal candidates for flexible designs, as higher utility encourages reconfiguration and justifies a flexibility premium. We also discover a non‐obvious relationship between optimal product strategy and dynamic consumer preferences. Intuition suggests that product flexibility would be more valuable when consumer preferences are less predictable. Instead, we find that a flexible product does not always lead to higher profits when consumer preferences are more uncertain; flexibility is most profitable when preference uncertainty is in an intermediate range. Additionally, we derive insights regarding the role of consumer patience, unit production costs, utility and durability differences between flexible and standard products, and heterogeneity in consumers’ product valuations. We find that imperfect durability can be an advantage for flexible products, and that heterogeneity can lead to a hybrid optimal product strategy, where offering a mix of flexible and standard products enables price discrimination between high‐ and low‐valuation consumers.

Keywords: Product strategy; New product design; Product variety management; Post‐purchase product variety; Delayed product differentiation; Postponement